ZYVERSA THERAPEUTICS, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ZYVERSA THERAPEUTICS, INC. stock issued during period, value, issued for services for the quarter ending 2025-09-30 was $29.60K.
- ZYVERSA THERAPEUTICS, INC. stock issued during period, value, issued for services for the quarter ending 2025-06-30 was $128.80K.
- ZYVERSA THERAPEUTICS, INC. stock issued during period, value, issued for services for the quarter ending 2025-03-31 was $81.60K, a 3.03% increase year-over-year.
- ZYVERSA THERAPEUTICS, INC. stock issued during period, value, issued for services for the quarter ending 2024-03-31 was $79.20K, a 79.96% decline year-over-year.
- ZYVERSA THERAPEUTICS, INC. stock issued during period, value, issued for services for fiscal 2025 was $240.00K, a 21.97% increase from fiscal 2024.
- ZYVERSA THERAPEUTICS, INC. stock issued during period, value, issued for services for fiscal 2024 was $196.77K, a 70.70% decline from fiscal 2023.
- ZYVERSA THERAPEUTICS, INC. stock issued during period, value, issued for services for fiscal 2023 was $671.62K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2025-12-31 | $240.00K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $29.60K 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $128.80K 10-Q · filed 2025-11-19 | |
| 2025-03-31 | $81.60K 10-Q · filed 2026-05-13 | |
| 2024-12-31 | $196.77K 10-K · filed 2026-03-31 | |
| 2024-03-31 | $79.20K 10-Q · filed 2025-11-19 | |
| 2023-12-31 | $671.62K 10-K · filed 2025-03-27 | |
| 2023-06-30 | $210.00K 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $395.20K 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |